{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:19:20Z","timestamp":1791317960111,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ahj.2014.01.017","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T03:31:04Z","timestamp":1393644664000},"page":"826-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: An ancillary study of the National Heart, Lung, and Blood Institute\u2013sponsored Women's Ischemia Syndrome Evaluation"],"prefix":"10.1016","volume":"167","clinical-trial-number":[{"clinical-trial-number":"nct00187889","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Anthony A.","family":"Bavry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Handberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyao","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshed A.","family":"Quyyumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrisandra","family":"Shufelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Noel Bairey","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda M.","family":"Cooper-DeHoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sopko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Pepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2014.01.017_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0735-1097(01)01308-0","article-title":"Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators","volume":"38","author":"Lagerqvist","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.01.017_bb0010","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1001\/jama.288.24.3124","article-title":"Benefit of an early invasive management strategy in women with acute coronary syndromes","volume":"288","author":"Glaser","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2014.01.017_bb0015","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ehj.2004.07.032","article-title":"Do men benefit more than women from an interventional strategy in patients with unstable angina or non\u2013ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial","volume":"25","author":"Clayton","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2014.01.017_bb0020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2014.01.017_bb0025","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.105.609990","article-title":"The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health\u2013National Heart, Lung, and Blood Institute\u2013sponsored Women's Ischemia Syndrome Evaluation","volume":"114","author":"Shaw","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.01.017_bb0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","article-title":"Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project","volume":"169","author":"Gulati","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2014.01.017_bb0035","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.01.017_bb0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.CIR.0000115525.92645.16","article-title":"Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute\u2013sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"109","author":"von Mering","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.01.017_bb0045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.CIR.0000025404.78001.D8","article-title":"Prognostic value of coronary vascular endothelial dysfunction","volume":"106","author":"Halcox","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.01.017_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2011.02.044","article-title":"Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials","volume":"216","author":"Shahin","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2014.01.017_bb0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2014.01.017_bb0060","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1523-1755.2004.00913.x","article-title":"Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats","volume":"66","author":"Fujisawa","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2014.01.017_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ndt\/gfn448","article-title":"Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats","volume":"24","author":"Kang","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ahj.2014.01.017_bb0070","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/01.ju.0000140445.82949.54","article-title":"Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction","volume":"172","author":"Trachtman","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ahj.2014.01.017_bb0075","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/01.hjh.0000249690.88865.90","article-title":"Use of antagonists of aldosterone in patients with chronic kidney disease: potential advantages and risks","volume":"24","author":"Campese","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2014.01.017_bb0080","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2014.01.017_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","article-title":"Effectiveness of aldosterone blockade in patients with diabetic nephropathy","volume":"41","author":"Sato","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2014.01.017_bb0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(01)80115-3","article-title":"Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications","volume":"37","author":"Epstein","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2014.01.017_bb0095","first-page":"B4265","article-title":"The renin-angiotensin-aldosterone system and its blockade in diabetic nephropathy: main focus on the role of aldosterone","volume":"58","author":"Schjoedt","year":"2011","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ahj.2014.01.017_bb0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2014.01.017_bb0105","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cardiores.2007.07.008","article-title":"Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence","volume":"76","author":"Min","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2014.01.017_bb0110","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/ATVBAHA.108.168021","article-title":"Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src\u2013regulated redox-sensitive RhoA pathways","volume":"28","author":"Montezano","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2014.01.017_bb0115","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0735-1097(99)00082-0","article-title":"The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report","volume":"33","author":"Merz","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.01.017_bb0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9149(01)01424-2","article-title":"Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory)","volume":"87","author":"Sharaf","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2014.01.017_bb0125","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0735-1097(99)00072-8","article-title":"Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study","volume":"33","author":"Reis","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.01.017_bb0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2014.01.017_bb0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.01.017_bb0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.112.972794","article-title":"Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"6","author":"Shah","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2014.01.017_bb0145","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.01.017_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2014.01.017_bb0155","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.112.110536","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations","volume":"126","author":"Rogers","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2014.01.017_bb0160","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.27.5.1031","article-title":"Improvement of coronary flow reserve after long-term therapy with enalapril","volume":"27","author":"Motz","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2014.01.017_bb0165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004872-199715020-00011","article-title":"Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy","volume":"15","author":"Rizzoni","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2014.01.017_bb0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/diacare.21.4.631","article-title":"Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension","volume":"21","author":"Giugliano","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2014.01.017_bb0175","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/10739680701410827","article-title":"Effect of the angiotensin receptor blocker Valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease","volume":"14","author":"Higuchi","year":"2007","journal-title":"Microcirculation"},{"key":"10.1016\/j.ahj.2014.01.017_bb0180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2010.08.004","article-title":"The discovery of endothelin: the power of bioassay and the role of serendipity in the discovery of endothelium-derived vasoactive substances","volume":"63","author":"Rubanyi","year":"2011","journal-title":"Pharmacol Res"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031400091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031400091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:52:11Z","timestamp":1757569931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287031400091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S000287031400091X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2014.01.017","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: An ancillary study of the National Heart, Lung, and Blood Institute\u2013sponsored Women's Ischemia Syndrome Evaluation","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2014.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mosby, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}